scispace - formally typeset
Open AccessJournal ArticleDOI

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

Reads0
Chats0
TLDR
Using MP-MRI to triage men might allow 27% of patients avoid a primary biopsy and diagnosis of 5% fewer clinically insignificant cancers, as well as reduce unnecessary biopsies by a quarter.
About
This article is published in The Lancet.The article was published on 2017-02-25 and is currently open access. It has received 2107 citations till now. The article focuses on the topics: Prostate biopsy & Transperineal biopsy.

read more

Citations
More filters
Journal ArticleDOI

Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.

TL;DR: Obtaining a multiparametric MRI before biopsy in biopsy-naive patients can improve the detection of clinically significant prostate cancer but does not seem to avoid the need for systematic biopsy.
Journal ArticleDOI

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis

TL;DR: Among patients with MRI-visible lesions, combined biopsy led to more detection of all prostate cancers, however, MRI-targeted biopsy alone underestimated the histologic grade of some tumors.
References
More filters
Journal ArticleDOI

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

TL;DR: Current evidence is insufficient to warrant widespread population-based screening by prostate-specific antigen (PSA) for PCa, and these EAU guidelines on PCa summarise the most recent findings and put them into clinical practice.
Journal ArticleDOI

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer.

TL;DR: The authors calculated the probability at birth of having a diagnosis of prostate cancer within a man's life to be 8.8% and subtracted the incidence of microscopic Stage A cancers too small to ever be clinically significant.
Related Papers (5)